Ratios Uncovered: Breaking Down Genius Sports Limited (GENI)’s Trailing Twelve Months Metrics

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Genius Sports Limited (NYSE: GENI) closed at $6.83 in the last session, up 2.71% from day before closing price of $6.65. In other words, the price has increased by $2.71 from its previous closing price. On the day, 2.06 million shares were traded. GENI stock price reached its highest trading level at $6.862 during the session, while it also had its lowest trading level at $6.655.

Ratios:

We take a closer look at GENI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 59.06. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

On April 16, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $7.50.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 1475553152 and an Enterprise Value of 1327420800. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.31 while its Price-to-Book (P/B) ratio in mrq is 2.62. Its current Enterprise Value per Revenue stands at 3.048 whereas that against EBITDA is -49.832.

Stock Price History:

Over the past 52 weeks, GENI has reached a high of $8.45, while it has fallen to a 52-week low of $4.62. The 50-Day Moving Average of the stock is 22.24%, while the 200-Day Moving Average is calculated to be 18.59%.

Shares Statistics:

According to the various share statistics, GENI traded on average about 2.02M shares per day over the past 3-months and 3160800 shares per day over the past 10 days. A total of 209.12M shares are outstanding, with a floating share count of 153.14M. Insiders hold about 27.39% of the company’s shares, while institutions hold 64.26% stake in the company. Shares short for GENI as of 1721001600 were 9306737 with a Short Ratio of 4.61, compared to 1718323200 on 9087662. Therefore, it implies a Short% of Shares Outstanding of 9306737 and a Short% of Float of 6.0100004.

Most Popular